Devon Medical Receives Clearance for Wound Care Device

The device utilizes suction pressure to accelerate healing.

Devon Medical Products, based in King of Prussia, Pa., has received 510(k) clearance from the U.S. Food and Drug Administration for its extriCARE 2400 negative pressure wound therapy (NPWT) system.

The extriCARE 2400 is a pump and bandage combination that creates negative pressure, or suction, over the wound. The anatomically fitted bandages create a seal around the area and can be used on various parts of the body. Via the suction, blood is drawn to the wound bed and exudates are collected in a disposable canister. Devon notes that the 8.6-ounce extriCARE pump should accelerate wound healing and shorten the amount of time spent on wound preparation.

Specific wounds the device is designed to manage are chronic, acute, traumatic, subacute and dehisced wounds, partial-thickness burns, diabetic and pressure ulcers, flaps, and grafts. extriCARE can be used in acute hospital settings, wound clinics, nursing homes, and inside the home under supervision of a trained healthcare professional, according to the company. The device is still pending a patent.

Devon Medical Products is a global medical device manufacturer, designer, and distributor. The company primarily is focused on devices that treat various types of swelling and wounds related to disease states ranging from lymphedema to diabetes.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters